The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
766
May 20, 1988
View Complete Issue         Table of Contents 2019 
Mupirocin - A New Topical Antibiotic
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Mupirocin - A New Topical Antibiotic
May 20, 1988 (Issue: 766)
Mupirocin (Bactroban - Beecham), a topical antibiotic formerly called pseudomonic acid, was recently approved by the US Food and Drug Administration for treatment of impetigo. It will be sold as a 2% ointment available only by prescription.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Mupirocin - A New Topical Antibiotic
Article code: 766b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.